Trial Summary
What is the purpose of this trial?
This clinical trial studies examines a 3D magnetic resonance imaging (MRI) compared to standard MRI imaging techniques in screening patients with prostate cancer. Diagnostic procedures, such as MRI, may help find and diagnose prostate cancer. Computer systems that allow doctors to create a 3-dimensional (3-D) picture of the tumor may help in planning.
Eligibility Criteria
This trial is for men aged 18 or older with intermediate to high-risk prostate cancer that hasn't been treated yet. They must be considering a radical prostatectomy (surgery to remove the prostate) and able to undergo scanning with a 3T magnet MRI. Exclusions include having a pacemaker, metal in the pelvis/spine, active cancers within 2 years, claustrophobia, low-risk cancer types or specific cellular features.Inclusion Criteria
You are being considered for a surgery called radical prostatectomy to treat your prostate cancer with the goal of curing it.
Patient has provided written informed consent for participation in this trial
Male, age >= 18
See 2 more
Exclusion Criteria
You have a pacemaker for your heart.
You have metal implants in your spine or pelvis.
You had another type of cancer within the past two years that is still active.
See 4 more
Treatment Details
Interventions
- Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques (Imaging Technique)
Trial OverviewThe study is testing how well a new type of 3D MRI technique works compared to standard MRI methods in screening patients with prostate cancer. The goal is to see if this new imaging can create better three-dimensional pictures of tumors which may improve diagnosis and treatment planning.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Screening (3D MRI)Experimental Treatment1 Intervention
Patients undergo 3D MRI imaging over 15 minutes with standard of care MRI or at a separate time.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...
Who Is Running the Clinical Trial?
M.D. Anderson Cancer CenterLead Sponsor